NLRP3 and atrial fibrillation: A study made in a mice model showed that NLRP3 inflammasome activation was associated with aberrant calcium release, atrial hypertrophy, and shortening of the effective refractory period, and the genetic inhibition of NLRP3 prevented the development of AF [123].